date,title,source
Nov-09-18,Vaxart Announces Third Quarter 2018 Financial Results and Provides Corporate Update,Business Wire
Nov-28-18,Vaxart to Present at World Vaccine and Immunotherapy Congress West Coast 2018,Business Wire
Feb-06-19,Vaxart Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update,Business Wire
Mar-19-19,Watch These Four Healthcare Stocks Set The Pace On Tuesday,ACCESSWIRE
Mar-19-19,Vaxart Announces $3 Million Registered Direct Offering Priced At-the-Market,Business Wire
Mar-19-19,Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial,Business Wire
Mar-20-19,Vaxart Announces Closing of Registered Direct Offering of Common Stock,Business Wire
Mar-27-19,Vaxart Completes Dosing of the Lead-In Cohort in Bivalent Norovirus Vaccine Phase 1b Clinical Trial,Business Wire
Mar-28-19,Vaxart to Present at Global Medical Meetings in April,Business Wire
Apr-09-19,Vaxart Announces Pricing of Underwritten Public Offering,Business Wire
Apr-12-19,Vaxart to Present at the 29th European Congress of Clinical Microbiology & Infectious Diseases,Business Wire
Apr-16-19,Vaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial,Business Wire
May-07-19,"Have Insiders Been Buying Vaxart, Inc. (NASDAQ:VXRT) Shares?",Simply Wall St.
May-09-19,Vaxart Announces First Quarter 2019 Financial Results and Provides Corporate Update,Business Wire
